We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 576.00 | 5.07% | 11,928.00 | 11,926.00 | 11,930.00 | 12,086.00 | 11,850.00 | 11,890.00 | 900,096 | 10:25:38 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.06 | 184.94B |
From Apr 2021 to Apr 2024
By Jaime Llinares Taboada
AstraZeneca PLC said Tuesday that it will invest $360 million in a manufacturing facility in Ireland.
The pharmaceutical company said it is planning to build an active pharmaceutical ingredient-manufacturing facility for small molecules near Dublin to ensure that its supply network is fit for future growth.
The plant will allow for late-stage development and early commercial supply, AstraZeneca said. It will create 100 direct jobs and further indirect jobs.
Write to Jaime Llinares Taboada at jaime.llinares@wsj.com; @JaimeLlinaresT
(END) Dow Jones Newswires
September 21, 2021 02:23 ET (06:23 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
